Hear from Joseph Arron, Genentech, Matt Sleeman, Regeneron and Brent McKenzie, Genentech, followed by a Q&A panel discussion moderated by Damien Bates, Biocurate.
Major landmark development will significantly increase CSL’s presence in the Parkville biomedical precinct and cement Melbourne’s place as a world-class research destination
CSL’s Chief Executive Officer, Mr Paul Perreault, at the CSL Centenary Celebration Gala announcing the establishment of a new flagship $25 million fellowship program for early stage and translational research in Australia